← Leaderboards
Steven A. Carr
Massachusetts Institute Of Technology
$47,532,757
Attributed
$102,641,773
Total exposure
32
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.5M · FY2006–25$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$115,890,465 · 33
By mechanism
U24$56,930,879 · 5
U19$26,871,258 · 19
R01$11,227,351 · 2
U01$10,937,956 · 2
RC2$4,800,000 · 1
DP3$4,160,310 · 1
Top collaborators
- Sarah M Fortune45 shared
- Thomas R Ioerger45 shared
- Kyu Y Rhee45 shared
- Dirk Schnappinger45 shared
- Robert E Gerszten15 shared
- Eric Joseph Rubin15 shared
- Clary B Clish11 shared
- Michael A Gillette11 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Li-Huei Tsai$66,135,710
- David K. Gifford$23,199,191
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsProteomicsTechnologyBaseGenesSamplingPathway InteractionsProgramsInsightMycobacterium TuberculosisGeneticPhenotypeCommunitiesData SetSignal TransductionResearch PersonnelGrowthProteomeMutationMass Spectrum AnalysisGenomicsMetabolomicsMolecularMalignant Neoplasms
Grant awards (107)
A biochemical roadmap of exercise signal$1,785,399
U24 · FY2025 · DK
Center of Excellence for High Throughput Proteogenomic Characterization$1,088,025
U24 · FY2025 · CA · contact PI
Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer$803,945
U01 · FY2025 · CA
Proteomics$192,725
P01 · FY2025 · CA · contact PI
Center of Excellence for High Throughput Proteogenomic Characterization$1,019,814
U24 · FY2024 · CA · contact PI
Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer$999,718
U01 · FY2024 · CA
Proteomics$182,542
P01 · FY2024 · CA · contact PI
A biochemical roadmap of exercise signal$1
U24 · FY2024 · DK
Center of Excellence for High Throughput Proteogenomic Characterization$1,066,337
U24 · FY2023 · CA · contact PI
Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer$1,032,286
U01 · FY2023 · CA
Proteomics$188,873
P01 · FY2023 · CA · contact PI
A Biochemical Roadmap of Exercise Signaling$1,651,155
U24 · FY2022 · DK
Mapping protein communication between organs in homeostasis and disease$1,638,633
R01 · FY2022 · DK
Center of Excellence for High Throughput Proteogenomic Characterization$1,088,100
U24 · FY2022 · CA · contact PI
Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer$1,084,271
U01 · FY2022 · CA
Proteomics$188,892
P01 · FY2022 · CA · contact PI
A Biochemical Roadmap of Exercise Signaling$2,400,207
U24 · FY2021 · DK
Mapping protein communication between organs in homeostasis and disease$1,642,113
R01 · FY2021 · DK
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS$1,396,406
U01 · FY2021 · CA
A Biochemical Roadmap of Exercise Signaling$1,291,879
U24 · FY2021 · DK
Proteomics$196,679
P01 · FY2021 · CA · contact PI
A Biochemical Roadmap of Exercise Signaling$2,777,531
U24 · FY2020 · DK
Mapping protein communication between organs in homeostasis and disease$1,645,489
R01 · FY2020 · DK
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS$1,403,852
U01 · FY2020 · CA
Center of Excellence for High Throughput Proteogenomic Characterization$1,286,216
U24 · FY2020 · CA · contact PI
A Biochemical Roadmap of Exercise Signaling$2,578,253
U24 · FY2019 · DK
Mapping protein communication between organs in homeostasis and disease$1,648,771
R01 · FY2019 · DK
A Biochemical Roadmap of Exercise Signaling$1,430,327
U24 · FY2019 · DK
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS$1,351,343
U01 · FY2019 · CA
Center of Excellence for High Throughput Proteogenomic Characterization$1,249,405
U24 · FY2019 · CA · contact PI
The 2019 Conference of the United States Human Proteome Organization (US HUPO)$13,000
R13 · FY2019 · CA
Mapping protein communication between organs in homeostasis and disease$1,704,079
R01 · FY2018 · DK
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS$1,413,657
U01 · FY2018 · CA
A Biochemical Roadmap of Exercise Signaling$1,335,796
U24 · FY2018 · DK
Center of Excellence for High Throughput Proteogenomic Characterization$1,288,045
U24 · FY2018 · CA · contact PI
Decoding the roles of critical genes of unknown function in M. tuberculosis$2,581,462
U19 · FY2017 · AI
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS$1,452,478
U01 · FY2017 · CA
Center of Excellence for High Throughput Proteogenomic Characterization$1,288,045
U24 · FY2017 · CA · contact PI
Data Management and Resource Dissemination Core$679,583
U19 · FY2017 · AI
Technology Core: Sequencing$569,304
U19 · FY2017 · AI
The roles of genes critical for growth in vitro$411,169
U19 · FY2017 · AI
The roles of biologically relevant ncRNAs$400,266
U19 · FY2017 · AI
Administrative Core$309,494
U19 · FY2017 · AI
Technology Core: Metabolomics and Biochemistry$237,448
U19 · FY2017 · AI
Technology Core: Proteomics$167,099
U19 · FY2017 · AI · contact PI
The roles of genes critical for growth under defined conditions in vitro or duri$161,656
U19 · FY2017 · AI
A Biochemical Roadmap of Exercise Signaling - Pilot Project for MoTrPAC Consortium$116,893
U24 · FY2017 · DK
A Biochemical Roadmap of Exercise Signaling$112,250
U24 · FY2017 · DK
Deciphering the molecular basis of T1D in human cells using functional genomics$4,160,310
DP3 · FY2016 · DK
Decoding the roles of critical genes of unknown function in M. tuberculosis$2,581,462
U19 · FY2016 · AI
Center of Excellence for High Throughput Proteogenomic Characterization$1,288,045
U24 · FY2016 · CA · contact PI
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers$825,543
U24 · FY2016 · CA · contact PI
The roles of genes critical for growth in vitro$669,700
U19 · FY2016 · AI
The roles of genes critical for growth under defined conditions in vitro or duri$593,390
U19 · FY2016 · AI
Technology Core: Metabolomics and Biochemistry$458,561
U19 · FY2016 · AI
The roles of biologically relevant ncRNAs$275,593
U19 · FY2016 · AI
Technology Core: Proteomics$184,037
U19 · FY2016 · AI · contact PI
Technology Core: Sequencing$173,290
U19 · FY2016 · AI
Data Management and Resource Dissemination Core$132,392
U19 · FY2016 · AI
Administrative Core$113,816
U19 · FY2016 · AI
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers$3,155,021
U24 · FY2015 · CA · contact PI
Decoding the roles of critical genes of unknown function in M. tuberculosis$2,782,563
U19 · FY2015 · AI
The roles of genes critical for growth under defined conditions in vitro or duri$672,898
U19 · FY2015 · AI
The roles of genes critical for growth in vitro$667,273
U19 · FY2015 · AI
Technology Core: Metabolomics and Biochemistry$449,492
U19 · FY2015 · AI
The roles of biologically relevant ncRNAs$279,487
U19 · FY2015 · AI
Technology Core: Proteomics$249,287
U19 · FY2015 · AI · contact PI
Technology Core: Sequencing$169,933
U19 · FY2015 · AI
Administrative Core$160,503
U19 · FY2015 · AI
Data Management and Resource Dissemination Core$133,690
U19 · FY2015 · AI
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers$3,023,578
U24 · FY2014 · CA · contact PI
Decoding the roles of critical genes of unknown function in M. tuberculosis$2,581,322
U19 · FY2014 · AI
The roles of genes critical for growth in vitro$662,658
U19 · FY2014 · AI
The roles of genes critical for growth under defined conditions in vitro or duri$521,480
U19 · FY2014 · AI
Technology Core: Metabolomics and Biochemistry$452,330
U19 · FY2014 · AI
The roles of biologically relevant ncRNAs$283,223
U19 · FY2014 · AI
Technology Core: Proteomics$249,896
U19 · FY2014 · AI · contact PI
Technology Core: Sequencing$169,486
U19 · FY2014 · AI
Data Management and Resource Dissemination Core$128,066
U19 · FY2014 · AI
Administrative Core$114,183
U19 · FY2014 · AI
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers$3,019,843
U24 · FY2013 · CA · contact PI
Decoding the roles of critical genes of unknown function in M. tuberculosis$2,721,883
U19 · FY2013 · AI
The roles of genes critical for growth in vitro$684,551
U19 · FY2013 · AI
The roles of genes critical for growth under defined conditions in vitro or duri$612,109
U19 · FY2013 · AI
Technology Core: Metabolomics and Biochemistry$464,355
U19 · FY2013 · AI
The roles of biologically relevant ncRNAs$287,071
U19 · FY2013 · AI
Technology Core: Proteomics$256,103
U19 · FY2013 · AI · contact PI
Technology Core: Sequencing$174,795
U19 · FY2013 · AI
Data Management and Resource Dissemination Core$130,245
U19 · FY2013 · AI
Administrative Core$112,654
U19 · FY2013 · AI
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers$3,122,514
U24 · FY2012 · CA · contact PI
Discovery & Application of Proteomics-Based Biomarkers of Early Myocardial Injury$737,576
R01 · FY2012 · HL
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers$3,034,910
U24 · FY2011 · CA · contact PI
Discovery & Application of Proteomics-Based Biomarkers of Early Myocardial Injury$750,332
R01 · FY2011 · HL
Measuring Cancer Biomarker Candidates by Targeted MS and Ab Enrichment$2,885,110
U24 · FY2010 · CA · contact PI
Measurement of Cancer-Associated Biomarker Proteins in Complex Biological Samples$1,594,648
RC2 · FY2010 · CA
Discovery & Application of Proteomics-Based Biomarkers of Early Myocardial Injury$721,603
R01 · FY2010 · HL
Measurement of Cancer-Associated Biomarker Proteins in Complex Biological Samples$3,205,352
RC2 · FY2009 · CA
Measuring Cancer Biomarker Candidates by Targeted MS and Ab Enrichment$2,833,858
U24 · FY2009 · CA · contact PI
Discovery & Application of Proteomics-Based Biomarkers of Early Myocardial Injury$738,755
R01 · FY2009 · HL
Measuring Cancer Biomarker Candidates by Targeted MS and Ab Enrichment$399,902
U24 · FY2009 · CA · contact PI
Measuring Cancer Biomarker Candidates by Targeted MS and Ab Enrichment$1,758,222
U24 · FY2008 · CA · contact PI
Measuring Cancer Biomarker Candidates by Targeted MS and Ab Enrichment$989,858
U24 · FY2008 · CA · contact PI
Measuring Cancer Biomarker Candidates by Targeted MS and Ab Enrichment$56,574
U24 · FY2008 · CA · contact PI
Measuring Cancer Biomarker Candidates by Targeted MS and Ab Enrichment$2,764,919
U24 · FY2007 · CA · contact PI
Measuring Cancer Biomarker Candidates by Targeted MS and Ab Enrichment$15,000
U24 · FY2007 · CA · contact PI
Measuring Cancer Biomarker Candidates by Targeted MS and Ab Enrichment$2,904,304
U24 · FY2006 · CA · contact PI